These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1384499)

  • 1. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes.
    Kuppusamy UR; Das NP
    Biochem Pharmacol; 1992 Oct; 44(7):1307-15. PubMed ID: 1384499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of beta-adrenoceptor agonist-mediated lipolysis by quercetin and fisetin in isolated rat adipocytes.
    Kuppusamy UR; Das NP
    Biochem Pharmacol; 1994 Feb; 47(3):521-9. PubMed ID: 7906943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylxanthine and non-xanthine phosphodiesterase inhibitors. Their effects on adenosine uptake and the low Km cyclic AMP phosphodiesterase in intact rat adipocyte.
    Wong EH; Ooi SO
    Biochem Pharmacol; 1985 Aug; 34(16):2891-6. PubMed ID: 2411270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antilipolytic action of hesperetin in rat adipocytes.
    Kuppusamy UR; Das NP
    Planta Med; 1993 Dec; 59(6):508-12. PubMed ID: 8302948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
    Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1193-8. PubMed ID: 2481031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
    Xue B; Greenberg AG; Kraemer FB; Zemel MB
    FASEB J; 2001 Nov; 15(13):2527-9. PubMed ID: 11641262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of insulin-sensitive phosphodiesterase in insulin action.
    Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
    Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antilipolytic action of polyamines in isolated rat adipocytes.
    Richelsen B; Pedersen SB; Hougaard DM
    Biochem J; 1989 Jul; 261(2):661-5. PubMed ID: 2476118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on lipolysis due to dibutyryl cyclic AMP.
    Goko H; Takashima S; Shimizu S; Kagawa S; Matsuoka A
    Biochem J; 1984 May; 220(1):321-4. PubMed ID: 6204645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of lipolysis in adipocytes from fed rats, but not from starved rats, by inhibition of rolipram-sensitive phosphodiesterase 4.
    Nakamura J; Okamura N; Kawakami Y
    Arch Biochem Biophys; 2004 May; 425(1):106-14. PubMed ID: 15081899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of base-substituted and carboxyl-esterified analogues of griseolic acid, a potent cAMP phosphodiesterase inhibitor.
    Yasumoto T; Iijima Y; Kaneko M; Yamazaki M
    Biochem Pharmacol; 1992 May; 43(10):2073-81. PubMed ID: 1318049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic exposure of rat fat cells to insulin enhances lipolysis and activation of partially purified hormone-sensitive lipase.
    Kang ES; Betts D; Fain JN; Bahouth SW; Myers LK
    Diabetes; 1993 Oct; 42(10):1415-24. PubMed ID: 8397127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells.
    Fredholm BB; Lindgren E
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):64-71. PubMed ID: 6322517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.